GO:0031408 oxylipin biosynthetic process | Genes & Methods

Oxylipins are a large family of bioactive lipids generated by the oxidative metabolism of polyunsaturated fatty acids (PUFAs) such as arachidonic acid, linoleic acid, and alpha-linolenic acid [1,4]. The Gene Ontology term GO:0031408, oxylipin biosynthetic process, captures the chemical reactions and pathways that convert these PUFAs into oxygenated products including prostaglandins, leukotrienes, jasmonates, and specialized pro-resolving mediators [1,6]. This process is not merely a metabolic curiosity; it represents a central signaling hub that coordinates inflammation, tissue repair, and immune responses across kingdoms [1,7]. In plants, oxylipins such as jasmonates regulate defense and innate immune memory [6,7], while in mammals they control vascular tone, pain perception, and the resolution of inflammation [1,3]. For researchers, GO:0031408 provides a structured framework to annotate genes and pathways involved in lipid mediator production. The term encompasses multiple enzymatic steps: release of PUFAs from membrane phospholipids, oxygenation by cyclooxygenases (COX), lipoxygenases (LOX), or cytochrome P450 epoxygenases, and subsequent reduction, isomerization, or conjugation reactions [1,4]. Recent work has shown that mitochondrial beta-oxidation acts as a rheostat that controls oxylipin levels during bacterial inflammation, linking energy metabolism to lipid signaling. Moreover, oxylipins released from pyroptotic cells actively promote tissue repair, underscoring their therapeutic potential. Understanding oxylipin biosynthesis is therefore critical for drug discovery, biomarker development, and functional genomics. The emergence of the Parkinson's disease oxylipin-ome highlights how comprehensive lipid profiling can reveal disease-specific signatures. In this article, we integrate the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0031408, its key genes, regulatory mechanisms, and the CRISPR-based methods used to study it.

GO:0031408 oxylipin biosynthetic process is defined by QuickGO as the chemical reactions and pathways resulting in the formation of any oxylipin, a group of biologically active compounds formed by oxidative metabolism of polyunsaturated fatty acids. In simpler terms, it is the biochemical process that turns common dietary or membrane-derived fats into potent oxygenated signaling molecules. This process includes the initial oxygenation of PUFAs by enzymes such as lipoxygenases, cyclooxygenases, and cytochrome P450s, as well as downstream modifications that generate the final bioactive oxylipin species [1,4]. The term is a biological process and is synonymous with oxylipin anabolism, oxylipin biosynthesis, oxylipin formation, and oxylipin synthesis.

Oxylipin biosynthetic process is fundamentally important because it produces lipid mediators that act as local hormones to control inflammation, pain, blood flow, and tissue regeneration [1,3]. Unlike classical hormones, oxylipins are synthesized on demand and act near their site of production, making their biosynthetic pathways attractive targets for therapeutic intervention. The balance between pro-inflammatory and pro-resolving oxylipins determines the outcome of many diseases, from arthritis to neurodegeneration. In plants, oxylipins such as jasmonates are central to defense signaling and innate immune memory, highlighting the evolutionary conservation of this pathway [6,7]. Consequently, understanding GO:0031408 is essential for researchers in immunology, neuroscience, plant biology, and drug discovery.

The following genes and proteins are central to the oxylipin biosynthetic process, based on published literature.

The oxylipin biosynthetic process is regulated at multiple levels. Substrate availability is controlled by phospholipase A2 activity, which is activated by calcium and phosphorylation. Enzyme expression is regulated transcriptionally; for example, PTGS2 (COX-2) is induced by NF-kB and MAPK pathways during inflammation. Post-translational modifications, such as phosphorylation of COX-2, modulate catalytic activity. Mitochondrial beta-oxidation acts as a degradation pathway that limits oxylipin accumulation, and its inhibition can increase oxylipin levels. In plants, jasmonate biosynthesis is regulated by the JA-Ile feedback loop and by COI1-mediated signaling [6,7]. Additionally, oxylipins themselves can feedback to regulate their own production, as seen in the resolution phase of inflammation.

The emerging Parkinson's disease oxylipin-ome reveals that specific oxylipin species are altered in the brain and periphery of patients. Dysregulated oxylipin biosynthesis may contribute to neuroinflammation and oxidative stress, which are hallmarks of Parkinson's disease pathology. Targeting oxylipin enzymes with CRISPR models could help determine whether these lipid changes are causal or compensatory.

Oxylipins released from pyroptotic cells act as promoters of tissue repair, highlighting their dual role in inflammation and regeneration. Imbalances in pro-inflammatory versus pro-resolving oxylipins are linked to chronic inflammatory diseases such as arthritis and atherosclerosis. Mitochondrial beta-oxidation controls oxylipin metabolism during bacterial inflammation, suggesting that metabolic interventions could modulate disease outcomes.

In plants, oxylipins such as jasmonates are essential for defense against pathogens and for innate immune memory [6,7]. Mutations in jasmonate biosynthetic genes compromise plant immunity, making them targets for crop improvement. Understanding plant oxylipin biosynthesis can also inform agricultural practices and food security.

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the gold standard for quantifying oxylipins in biological samples [2,3]. This method can measure dozens of oxylipin species simultaneously, providing a comprehensive oxylipin-ome profile. It is used to validate CRISPR knockout effects on specific biosynthetic pathways.

Genome-wide CRISPR knockout screens can identify genes that regulate oxylipin production. By coupling oxylipin detection with pooled screening, researchers can discover novel biosynthetic enzymes or regulatory factors. This approach is particularly powerful for uncovering metabolic crosstalk.

RNA-seq and proteomics reveal expression changes in oxylipin biosynthetic enzymes under different conditions [1,6]. These methods help identify transcriptional regulators and post-transcriptional modifications that control pathway activity. In plants, transcriptomics has elucidated jasmonate signaling networks.

Cell-based assays such as calcium flux, cAMP measurement, or reporter gene activation can assess oxylipin signaling downstream of biosynthesis. In plants, jasmonate-responsive reporter lines are used to monitor pathway activity. These assays complement biochemical profiling [1,7].

Researchers studying oxylipin biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in lipid mediator production, inflammation resolution, or disease progression. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such functional studies.

GO:0031408 oxylipin biosynthetic process is a fundamental biological pathway that generates lipid mediators controlling inflammation, immunity, and tissue homeostasis across species [1,4]. Its dysregulation is implicated in major human diseases including Parkinson's disease and chronic inflammatory conditions [1,5]. Advances in CRISPR genome editing and oxylipinomics now enable precise functional dissection of this pathway, offering new opportunities for therapeutic intervention [3,5]. EDITGENE's suite of CRISPR services supports researchers in uncovering causal mechanisms and accelerating drug discovery in this rapidly evolving field.